Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis

EBioMedicine

Volumn 6, Issue , 2016, Pages 31-41

  Palmer, Clovis S ^a,b   Cherry, Catherine L ^a,b,c,d   Sada Ovalle, Isabel ^e   Singh, Amit ^f   Crowe, Suzanne M ^a,b,c  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^f INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Cardiovascular disease; CD4 T cells; CD8 T cells; Glucose transporter 1 (Glut1); HIV; HIV cure; HIV reservoir; Immune activation; Immunometabolism; Inflammation; Macrophage; Metabolism; Monocytes; Oxidative stress; SNAEs

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GLUCOSE TRANSPORTER 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHOENOLPYRUVATE; PROTEIN KINASE C; RANTES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; GLUCOSE;

CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE COURSE; EPSTEIN BARR VIRUS; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFLAMMATION; INFLUENZA VIRUS; METABOLIC REGULATION; MONOCYTE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; EPSTEIN BARR VIRUS INFECTION; IMMUNOLOGY; INFLUENZA; LYMPHOCYTE ACTIVATION; METABOLISM;

DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; GLUCOSE; HIV INFECTIONS; HUMANS; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; METABOLIC NETWORKS AND PATHWAYS; MONOCYTES; OXIDATIVE STRESS; T-LYMPHOCYTES;

EID: 84958582124     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.02.012     Document Type: Review

References (114)

1. Ai D., Jiang H., Westerterp M., Murphy A.J., Wang M., Ganda A., et al. Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis. Circ. Res. 2014, 114:1576-1584.
2. Alonso-Villaverde C., Menendez J.A., Joven J. Metabolic stress in infected cells may represent a therapeutic target for human immunodeficiency virus infection. Med. Hypotheses 2013, 81:125-130.
3. Alvarez Y., Tuen M., Shen G., Nawaz F., Arthos J., Wolff M.J., et al. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J. Virol. 2013, 87:10843-10854.
4. Andrisse S., Koehler R.M., Chen J.E., Patel G.D., Vallurupalli V.R., Ratliff B.A., et al. Role of GLUT1 in regulation of reactive oxygen species. Redox Biol. 2014, 2:764-771.
5. Arruvito L., Sabatte J., Pandolfi J., Baz P., Billordo L.A., Lasala M.B., et al. Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients. PLoS One 2012, 7.
6. Aukrust P., Svardal A.M., Muller F., Lunden B., Berge R.K., Ueland P.M., et al. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 1995, 86:258-267.
7. Bajwa G., DeBerardinis R.J., Shao B., Hall B., Farrar J.D., Gill M.A. Cutting edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses. J. Immunol. 2016.
8. Banki K., Hutter E., Colombo E., Gonchoroff N.J., Perl A. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 1996, 271:32994-33001.
9. Banki K., Hutter E., Gonchoroff N.J., Perl A. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 1998, 273:11944-11953.
10. Barghouthi S., Everett K.D., Speert D.P. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of d-glucose by macrophages. J. Immunol. 1995, 154:3420-3428.
11. Barrero C.A., Datta P.K., Sen S., Deshmane S., Amini S., Khalili K., et al. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One 2013, 8.
12. Basu S., Hubbard B., Shevach E.M. Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. J. Leukoc. Biol. 2015, 97:279-283.
13. Bhaskar A., Munshi M., Khan S.Z., Fatima S., Arya R., Jameel S., et al. Measuring glutathione redox potential of HIV-1 infected macrophages. J. Biol. Chem. 2014.
14. Bhaskar A., Munshi M., Khan S.Z., Fatima S., Arya R., Jameel S., et al. Measuring glutathione redox potential of HIV-1-infected macrophages. J. Biol. Chem. 2015, 290:1020-1038.
15. Cecchinato V., Trindade C.J., Laurence A., Heraud J.M., Brenchley J.M., Ferrari M.G., et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008, 1:279-288.
16. Chang S.H., Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 2007, 17:435-440.
17. Chang C.H., Curtis J.D., Maggi L.B., Faubert B., Villarino A.V., O'Sullivan D., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013, 153:1239-1251.
18. Cheng S.C., Quintin J., Cramer R.A., Shepardson K.M., Saeed S., Kumar V., et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014, 345:1250684.
19. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 2009, 15:893-900.
20. Cooper A., Garcia M., Petrovas C., Yamamoto T., Koup R.A., Nabel G.J. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013, 498:376-379.
21. Cox A.L., Siliciano R.F. HIV: not-so-innocent bystanders. Nature 2014, 505:492-493.
22. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
23. Crome S.Q., Wang A.Y., Levings M.K. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin. Exp. Immunol. 2010, 159:109-119.
24. Dagenais-Lussier X., Mouna A., Routy J.P., Tremblay C., Sekaly R.P., El-Far M., et al. Current topics in HIV-1 pathogenesis: the emergence of deregulated immuno-metabolism in HIV-infected subjects. Cytokine Growth Factor Rev. 2015, 26:603-613.
25. Deeks S.G. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top. HIV Med. 2009, 17:118-123.
26. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011, 12:295-303.
27. Dietl K., Renner K., Dettmer K., Timischl B., Eberhart K., Dorn C., et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 2010, 184:1200-1209.
28. Doitsh G., Galloway N.L., Geng X., Yang Z., Monroe K.M., Zepeda O., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014, 505:509-514.
29. Doyon G., Sobolewski M.D., Huber K., McMahon D., Mellors J.W., Sluis-Cremer N. Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110alpha that reactivates latent HIV-1. PLoS One 2014, 9.
30. Fanales-Belasio E., Moretti S., Fiorelli V., Tripiciano A., Pavone Cossut M.R., Scoglio A., et al. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J. Immunol. 2009, 182:2888-2897.
31. Fernandez S., Tanaskovic S., Helbig K., Rajasuriar R., Kramski M., Murray J.M., et al. CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. J. Infect. Dis. 2011, 204:1927-1935.
32. Franklin C.C., Rosenfeld-Franklin M.E., White C., Kavanagh T.J., Fausto N. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J. 2003, 17:1535-1537.
33. Freemerman A.J., Johnson A.R., Sacks G.N., Milner J.J., Kirk E.L., Troester M.A., et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 2014, 289:7884-7896.
34. Frison H., Giono G., Thebault P., Fournier M., Labrecque N., Bijl J.J. Hoxb4 overexpression in CD4 memory phenotype T cells increases the central memory population upon homeostatic proliferation. PLoS One 2013, 8.
35. Fukuzumi M., Shinomiya H., Shimizu Y., Ohishi K., Utsumi S. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect. Immun. 1996, 64:108-112.
36. Gamelli R.L., Liu H., He L.K., Hofmann C.A. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J. Leukoc. Biol. 1996, 59:639-647.
37. Gerriets V.A., Kishton R.J., Nichols A.G., Macintyre A.N., Inoue M., Ilkayeva O., et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 2015, 125:194-207.
38. Giacomet V., Trabattoni D., Zanchetta N., Biasin M., Gismondo M., Clerici M., et al. No cure of HIV infection in a child despite early treatment and apparent viral clearance. Lancet 2014, 384:1320.
39. Hegedus A., Kavanagh Williamson M., Huthoff H. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 2014, 11:98.
40. Heredia A., Le N., Gartenhaus R.B., Sausville E., Medina-Moreno S., Zapata J.C., et al. Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:9412-9417.
41. Ho F.M., Liu S.H., Liau C.S., Huang P.J., Lin-Shiau S.Y. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000, 101:2618-2624.
42. Ho P.C., Bihuniak J.D., Macintyre A.N., Staron M., Liu X., Amezquita R., et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T Cell responses. Cell 2015, 162:1217-1228.
43. Hollenbaugh J.A., Munger J., Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology 2011, 415:153-159.
44. Hunt P.W., Martin J.N., Sinclair E., Epling L., Teague J., Jacobson M.A., et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J. Infect. Dis. 2011, 203:1474-1483.
45. Hunt P.W., Landay A.L., Sinclair E., Martinson J.A., Hatano H., Emu B., et al. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 2011, 6.
46. Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., et al. The mitochondrial citrate carrier: a new player in inflammation. Biochem. J. 2011, 438:433-436.
47. Izquierdo E., Cuevas V.D., Fernandez-Arroyo S., Riera-Borrull M., Orta-Zavalza E., Joven J., et al. Reshaping of human macrophage polarization through modulation of glucose catabolic pathways. J. Immunol. 2015, 195:2442-2451.
48. Johnson A.R., Milner J.J., Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 2012, 249:218-238.
49. Jones K.A., Peterlin B.M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 1994, 63:717-743.
50. Josefsson L., von Stockenstrom S., Faria N.R., Sinclair E., Bacchetti P., Killian M., et al. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4987-E4996.
51. Kachko I., Maissel A., Mazor L., Ben-Romano R., Watson R.T., Hou J.C., et al. Postreceptoral adipocyte insulin resistance induced by nelfinavir is caused by insensitivity of PKB/Akt to phosphatidylinositol-3,4,5-trisphosphate. Endocrinology 2009, 150:2618-2626.
52. Kastirr I., Crosti M., Maglie S., Paroni M., Steckel B., Moro M., et al. Signal strength and metabolic requirements control cytokine-induced Th17 differentiation of uncommitted human T cells. J. Immunol. 2015, 195:3617-3627.
53. Kinet S., Swainson L., Lavanya M., Mongellaz C., Montel-Hagen A., Craveiro M., et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 2007, 4:31.
54. Koenen T.B., Stienstra R., van Tits L.J., de Graaf J., Stalenhoef A.F., Joosten L.A., et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 2011, 60:517-524.
55. Kotler D.P. Antioxidant therapy and HIV infection: 1998. Am. J. Clin. Nutr. 1998, 67:7-9.
56. Kovitz C.A., Morgello S. Cerebral glucose transporter expression in HIV infection. Acta Neuropathol. 1997, 94:140-145.
57. Kumar P., Natarajan K., Shanmugam N. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression. Cell. Signal. 2014, 26:528-539.
58. Lan X., Cheng K., Chandel N., Lederman R., Jhaveri A., Husain M., et al. High glucose enhances HIV entry into T cells through upregulation of CXCR4. J. Leukoc. Biol. 2013, 94:769-777.
59. Locasale J.W., Cantley L.C. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011, 14:443-451.
60. Loftus R.M., Finlay D.K. Immunometabolism: cellular metabolism turns immune regulator. J. Biol. Chem. 2016, 291:1-10.
61. Loisel-Meyer S., Swainson L., Craveiro M., Oburoglu L., Mongellaz C., Costa C., et al. Glut1-mediated glucose transport regulates HIV infection. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2549-2554.
62. Ma K.L., Liu J., Gao M., Wang C.X., Ni J., Zhang Y., et al. Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal disease. Clin. Nephrol. 2014, 81:396-404.
63. Macintyre A.N., Gerriets V.A., Nichols A.G., Michalek R.D., Rudolph M.C., Deoliveira D., et al. The glucose transporter Glut1 is selectively essential for CD4 T Cell activation and effector function. Cell Metab. 2014, 20:61-72.
64. MacIver N.J., Michalek R.D., Rathmell J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
65. Maggi L., Santarlasci V., Capone M., Peired A., Frosali F., Crome S.Q., et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 2010, 40:2174-2181.
66. Maisa A., Hearps A.C., Angelovich T.A., Pereira C.F., Zhou J., Shi M.D., et al. Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. AIDS 2015, 29:1445-1457.
67. Malide D., Davies-Hill T.M., Levine M., Simpson I.A. Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation. Am. J. Physiol. 1998, 274:E516-E526.
68. Martinet W., De Loof H., De Meyer G.R. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis 2014, 233:601-607.
69. McFadden K., Hafez A.Y., Kishton R., Messinger J.E., Nikitin P.A., Rathmell J.C., et al. Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization. Proc. Natl. Acad. Sci. U. S. A. 2016.
70. Merrill J.E., Koyanagi Y., Chen I.S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 1989, 63:4404-4408.
71. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011, 186:3299-3303.
72. Mills E.L., O'Neill L.A. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur. J. Immunol. 2016, 46:13-21.
73. Morris D., Guerra C., Donohue C., Oh H., Khurasany M., Venketaraman V. Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin. Dev. Immunol. 2012, 2012:734125.
74. Nguyen D., Hsu J.W., Jahoor F., Sekhar R.V. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J. Clin. Endocrinol. Metab. 2014, 99:169-177.
75. Oestreich K.J., Read K.A., Gilbertson S.E., Hough K.P., McDonald P.W., Krishnamoorthy V., et al. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 2014, 15:957-964.
76. Omenetti S., Pizarro T.T. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Front. Immunol. 2015, 6:639.
77. O'Neill L.A., Pearce E.J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 2016, 213:15-23.
78. Palmer C.S., Crowe S.M. The role of glucose and lipid metabolism in the pathogenesis of HIV-1 infection. Curr. Trends Immunol. 2012, 13:37-50.
79. Palmer C.S., Crowe S.M. Panobinostat clinical trial highlights the challenges towards an HIV cure. Lancet HIV 2014, 1.
80. Palmer C.S., Crowe S.M. How does monocyte metabolism impact inflammation and aging during chronic HIV infection?. AIDS Res. Hum. Retrovir. 2014, 30:335-336.
81. Palmer C.S., Ostrowski M., Henstridge D.C., Lam L., Zhou J., Saleh S., et al. Glucose metabolism is an integral process in CD4+ T cell activation and inflammation in HIV-1 infected subjects. Keystone Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications, Colorado, USA 2013.
82. Palmer C.S., Ostrowski M., Gouillou M., Tsai L., Yu D., Zhou J., et al. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. AIDS 2014, 28:297-309.
83. Palmer C.S., Anzinger J.J., Zhou J., Gouillou M., Landay A., Jaworowski A., et al. Glut1 expressing pro-inflammatory monocytes are elevated in cART-treated and untreated HIV-1+ subjects. J. Immunol. 2014.
84. Palmer C.S., Hussain T., Duette G., Weller T.J., Ostrowski M., Sada-Ovalle I., et al. Regulators of glucose metabolism in CD4 and CD8 T cells. Int. Rev. Immunol. 2015, 1-12.
85. Palmer C.S., Ostrowski M., Balderson B., Christian N., Crowe S.M. Glucose metabolism regulates T cell activation, differentiation, and functions. Front. Immunol. 2015, 6:1.
86. Pereira L.A., Bentley K., Peeters A., Churchill M.J., Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 2000, 28:663-668.
87. Perl A., Banki K. Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antioxid. Redox Signal. 2000, 2:551-573.
88. Powell J.D., Pollizzi K.N., Heikamp E.B., Horton M.R. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 2011.
89. Purton J.F., Tan J.T., Rubinstein M.P., Kim D.M., Sprent J., Surh C.D. Antiviral CD4+ memory T cells are IL-15 dependent. J. Exp. Med. 2007, 204:951-961.
90. Rasmussen T.A., Tolstrup M., Brinkmann C.R., Olesen R., Erikstrup C., Solomon A., et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. Lancet HIV 2014, 1:e13-e21.
91. Rodriguez-Mora S., Mateos E., Moran M., Martin M.A., Lopez J.A., Calvo E., et al. Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication. Retrovirology 2015, 12:78.
92. Roederer M., Staal F.J., Osada H., Herzenberg L.A. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 1991, 3:933-937.
93. Roiniotis J., Dinh H., Masendycz P., Turner A., Elsegood C.L., Scholz G.M., et al. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 2009, 182:7974-7981.
94. Salzano S., Checconi P., Hanschmann E.M., Lillig C.H., Bowler L.D., Chan P., et al. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:12157-12162.
95. Sen S., Kaminiski R., Deshmane S., Langford D., Khalili K., Amini S., et al. Role of hexokinase-1 in the survival of HIV-1-infected macrophages. Cell Cycle 2015, 14:980-989.
96. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208:1367-1376.
97. Sierra-Filardi E., Nieto C., Dominguez-Soto A., Barroso R., Sanchez-Mateos P., Puig-Kroger A., et al. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J. Immunol. 2014, 192:3858-3867.
98. Sorbara L.R., Maldarelli F., Chamoun G., Schilling B., Chokekijcahi S., Staudt L., et al. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression. J. Virol. 1996, 70:7275-7279.
99. Stock P.G., Barin B., Hatano H., Rogers R.L., Roland M.E., Lee T.H., et al. Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. Am. J. Transplant. 2014, 14:1136-1141.
100. Sun H., Kim D., Li X., Kiselinova M., Ouyang Z., Vandekerckhove L., et al. Th1/17 polarization of CD4 T Cells supports HIV-1 persistence during antiretroviral therapy. J. Virol. 2015, 89:11284-11293.
101. Tanaskovic S., Fernandez S., French M.A., Price R.I., Song S., Robins P.D., et al. Thymic tissue is not evident on high-resolution computed tomography and [(1)(8)F]fluoro-deoxy-glucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4(+) T cells. AIDS 2011, 25:1235-1237.
102. Triplett T.A., Curti B.D., Bonafede P.R., Miller W.L., Walker E.B., Weinberg A.D. Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG. Eur. J. Immunol. 2012, 42:1893-1905.
103. Valverde-Villegas J.M., Matte M.C., de Medeiros R.M., Chies J.A. New insights about Treg and Th17 cells in HIV Infection and disease progression. J. Immunol. Res. 2015, 2015:647916.
104. Van den Bossche J., Baardman J., de Winther M.P. Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis. J. Vis. Exp. 2015.
105. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4:13-24.
106. Wagner T.A., McKernan J.L., Tobin N.H., Tapia K.A., Mullins J.I., Frenkel L.M. An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells. J. Virol. 2013, 87:1770-1778.
107. Williams A., Steffens F., Reinecke C., Meyer D. The Th1/Th2/Th17 cytokine profile of HIV-infected individuals: a multivariate cytokinomics approach. Cytokine 2013, 61:521-526.
108. Wu C.H., Wu C.F., Huang H.W., Jao Y.C., Yen G.C. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol. Nutr. Food Res. 2009, 53:984-995.
109. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
110. Yao K., Ge J.B., Sun A.J., Hong X.W., Shi H.Y., Huang R.C., et al. Effects and mechanism of hyperglycemia on development and maturation and immune function of human monocyte derived dendritic cells. Zhonghua Xin Xue Guan Bing Za Zhi 2006, 34:60-64.
111. Yilmaz S., Boffito M., Collot-Teixeira S., De Lorenzo F., Waters L., Fletcher C., et al. Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarrays. Genomics 2010, 96:57-65.
112. Yin Y., Choi S.C., Xu Z., Perry D.J., Seay H., Croker B.P., et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 2015, 7:274ra218.
113. Yin Y., Choi S.C., Xu Z., Zeumer L., Kanda N., Croker B.P., et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J. Immunol. 2016, 196:80-90.
114. Zheng Y., Delgoffe G.M., Meyer C.F., Chan W., Powell J.D., Anergic T. Cells are metabolically anergic. J. Immunol. 2009, 183:6095-6101.